Not all leaders are good leaders.Perhaps you’ve lost an important executive or you’re establishing a local leadership team. You know that the leader you choose will have a major impact on the organization. So how can you avoid hiring the…
HOME > ACADEMIA
ACADEMIA
- Cancer Researchers Call for Academia-Industry Collaboration via Japan NIH
December 9, 2014
- 22 Seeds Supported by Drug Discovery Support Network So Far: Dr Kurebayashi of NIBIO
December 9, 2014
- AIDS Treatment Extends Lives, but Many Problems Remain: Dr Mitsuya
December 1, 2014
- J-ARF Moving Into Full Gear as Academic Research Organization
December 1, 2014
- Next Year to See “Dawn of New Age” of Interferon-Free Hepatitis C Treatment: Dr Kumada
November 28, 2014
- Avigan’s Efficacy in Ebola “Unknown” with No Corroborative Data: NIID Official
November 27, 2014
- J-CLEAR’s Kuwajima Criticizes Plan to Legally Regulate Clinical Research
November 12, 2014
- ICH-GCP Compliance Obligatory for Clinical Studies Conducted by Chiba University
October 28, 2014
- Chiba University Issues Warning to Prof. Involved in VART Study
October 28, 2014
- JSH to Draft Guidelines on Clinical Research with Company Funding
October 21, 2014
- St. Marianna Hospital Elbows Drug Makers to Reveal Detailing Costs Embedded in Drug Prices
October 10, 2014
- Japanese Society of Hypertension Announces Resignation of President
October 1, 2014
- Rivaroxaban as Safe and Effective as Standard Therapy in Japanese DVT Patients: J-EINSTEIN DVT Study
September 30, 2014
- Safety and Efficacy of Secukinumab Confirmed for Psoriasis in Japanese Patients
September 24, 2014
- Dr Yui Poses Questions on Dabigatran Analysis Model on BMJ
September 9, 2014
- Prof. Komuro to Issue Objection to Chiba University in Wake of Second Retraction Request Related to VART Study
September 9, 2014
- Kyoto University, Astellas Aim to Develop Immunological Disease Cures, 11 Target Molecules Now under Screening
August 21, 2014
- Chiba Univ. Once Again Advises Authors to Withdraw Papers from VART Study
August 19, 2014
- Japanese Circulation Society Issues Warning Letter to Dr Matsubara and Co-Authors in Connection with Diovan Scandal
August 15, 2014
- JSH to Adopt Tougher COI Rule after Panel Said Novartis’s Involvement in SIGN Trial Should Have Been Disclosed at Conference
August 5, 2014
ページ
Earlier this month, Health Minister Keizo Takemi called on the top executives of 13 major generic makers to restructure the industry with a product consolidation target of “around five companies per API.” While a variety of restructuring options are conceivable,…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…